Allogeneic Hematopoietic Cell Transplantation for Relapsed / Refractory Hodgkin Lymphoma: A Multicenter Real-World Experience

Key Points

• To evaluate the efficacy of allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma.
• Multicenter observational study
• Focus on allogeneic hematopoietic cell transplantation
• Inclusion of patients with relapsed or refractory Hodgkin lymphoma
• AlloHCT shows potential benefits in treatment efficacy
• Improvement in patient responses observed
• Suggests alloHCT may be a viable option for treatment.